Logo

Bayer Launches a LifeHub UK for the Development of AI-Enabled Imaging Solutions Enhancing Data-Driven Drug Discovery and Disease Diagnosis

Share this

Bayer Launches a LifeHub UK for the Development of AI-Enabled Imaging Solutions Enhancing Data-Driven Drug Discovery and Disease Diagnosis

Shots:

  • LifeHub UK launch is the seventh pillar in Bayer’s WW network of LifeHubs targeting acceleration and optimization of disease detection and data-driven drug discovery utilizing AI-enabled imaging solutions. Bayer also signed an agreement with Sensyne Health- being the first company to enter LifeHub UK while companies will jointly conduct R&D activities for developing AI solutions  
  • The focus of the launch is to develop AI-enabled digital solutions based on Bayer’s knowledge and expertise in the medical imaging field delivering patient benefits with improved diagnoses enabling early disease management and detection
  • The Life Hub is in Reading’s Green Park at the heart of the Thames Valley boasting 45-000+ tech-related jobs and contributing 12B pound to UK annual digital technology revenues. Additionally- the six other centers LifeHubs are in Berlin- Boston- California- Lyon- Singapore and Tokyo/Osaka

Click here to­ read full press release/ article | Ref: Bayer | Image: Behance


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions